The FDA has recently issued a report advising against the use of buprenorphine and methadone medications in patients taking benzodiazepines and/or other central nervous system depressants.
WHO has updated its Essential Medicines List to include new recommendations on which antibiotics to use for common infections and serious conditions.
A ketamine regimen is superior to methadone, or ketamine combined with methadone, in alleviating neuropathic pain and associated sensory changes.
Practices pertaining to the use of methadone to facilitate opioid weaning in pediatric patients are widely heterogeneous.
Polymorphism at the level of drug receptors, transporters, or other proteins involved in drug metabolism or action may have an impact on the effect of a drug.
Throughout 2016, the FDA has announced requirements for manufacturers to create new product labeling information for a variety of opioid medications.
Clinical Pain Advisor Articles
- Virtual Reality for Pain Relief: Understanding the Underlying Mechanisms
- Vibrating Gloves Significantly Reduce Osteoarthritis-Related Hand Pain
- Neuroimaging for Chronic Pain: IASP Consensus Statement
- Neuroinflammation in Neuropathic Pain Indicated by Elevated Levels of Proinflammatory Chemokines in CSF
- Hypertension in Chronic Pain: Risk Factors
- Liposomal Bupivacaine Effective for Shoulder Arthroplasty-Related Pain
- Reducing the P-Value for Statistical Significance to Improve the Quality of Research?
- FDA's Strategies for Managing Patients Taking CNS Depressants and Opioids
- Electrotherapy, Acupuncture May Decrease Pain Following Total Knee Arthroplasty
- Low-Dose Oromucosal Ibuprofen Effective for Relieving Sore Throat
- Survey Finds Teens Divided on Beliefs and Attitudes of Prescription Drug Abuse
- HIV-Positive Patients Experience Frequent Headaches
- Low-Dose Perineural Dexamethasone Prolongs Effects of Brachial Plexus Nerve Block
- Business Savvy Tips for Buying a Practice
- Diphenhydramine Decreases Pain During Colonoscopy for Chronic Opioid Users